Institutional investors purchased a net $893.7 thousand shares of ATRS during the quarter ended March 2016. This may signal that the smart money is gaining interest in this company as the 43.11% of shares outstanding that institutional investors hold is actually below the Medical Specialties industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BROADFIN CAPITAL LLC Bought 3.6 Million shares of Antares Pharma Inc
MORGAN STANLEY & CO. LLC Bought 2.6 Million shares of Antares Pharma Inc
ARMISTICE CAPITAL LLC Bought 2.2 Million shares of Antares Pharma Inc